These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2257354

  • 1. First experience with BCG discontinuation in Europe. BCG vaccination and HIV infection.
    ten Dam HG.
    Bull Int Union Tuberc Lung Dis; 1990; 65(2-3):38-9. PubMed ID: 2257354
    [No Abstract] [Full Text] [Related]

  • 2. First experience with BCG discontinuation in Europe. Project on discontinuation of BCG vaccination in newborns in Czechoslovakia.
    Trnka L, Dankova D, Machova A, Svandova E, Hejdova E.
    Bull Int Union Tuberc Lung Dis; 1990; 65(2-3):36-7. PubMed ID: 2257353
    [No Abstract] [Full Text] [Related]

  • 3. First experience with BCG discontinuation in Europe. Experience in Sweden 15 years after stopping general BCG vaccination at birth.
    Romanus V.
    Bull Int Union Tuberc Lung Dis; 1990; 65(2-3):32-5. PubMed ID: 2257352
    [No Abstract] [Full Text] [Related]

  • 4. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, Godfrey-Faussett P, Beyers N.
    Vaccine; 2007 Jan 02; 25(1):14-8. PubMed ID: 16959383
    [Abstract] [Full Text] [Related]

  • 5. Novel vaccine prime and selective BCG boost: a new tuberculosis vaccine strategy for infants of HIV-infected mothers.
    Hatherill M, Mahomed H, Hanekom W.
    Vaccine; 2010 Jun 23; 28(29):4550-2. PubMed ID: 20470797
    [Abstract] [Full Text] [Related]

  • 6. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants.
    Hesseling AC, Cotton MF, Fordham von Reyn C, Graham SM, Gie RP, Hussey GD.
    Int J Tuberc Lung Dis; 2008 Dec 23; 12(12):1376-9. PubMed ID: 19017445
    [Abstract] [Full Text] [Related]

  • 7. Mycobacterium bovis lymphadenitis complicating BCG immunization in an infant with symptomatic HIV-1 infection.
    Marks K, Amitai Y, Engelhard D, Kori M, Maayan S.
    Isr J Med Sci; 1993 Dec 23; 29(6-7):381-2. PubMed ID: 8349456
    [Abstract] [Full Text] [Related]

  • 8. Evidence behind the WHO guidelines: hospital care for children: what is the evidence that BCG vaccination should not be used in HIV-infected children?
    Bannister C, Bennett L, Carville A, Azzopardi P.
    J Trop Pediatr; 2009 Apr 23; 55(2):78-82. PubMed ID: 19276146
    [No Abstract] [Full Text] [Related]

  • 9. [HIV-infection, AIDS and BCG vaccination].
    Toida I.
    Kekkaku; 1993 Jun 23; 68(6):435-44. PubMed ID: 8341039
    [Abstract] [Full Text] [Related]

  • 10. BCG vaccination in children.
    BMJ; 1990 Dec 01; 301(6763):1274-5. PubMed ID: 2091641
    [No Abstract] [Full Text] [Related]

  • 11. [Effectiveness of tuberculosis vaccines].
    Nechaeva OB, Arenskiĭ VA.
    Probl Tuberk; 2001 Dec 01; (1):13-4. PubMed ID: 11337770
    [Abstract] [Full Text] [Related]

  • 12. BCG and HIV reconsidered: moving the research agenda forward.
    Hesseling AC, Cotton MF, Marais BJ, Gie RP, Schaaf HS, Beyers N, Fine PE, Abrams EJ, Godfrey-Faussett P, Kuhn L.
    Vaccine; 2007 Sep 04; 25(36):6565-8. PubMed ID: 17659816
    [No Abstract] [Full Text] [Related]

  • 13. [Instructions on the use of dry tuberculosis vaccine (BCG) for intracutaneous administration in mass vaccination and revaccination against tuberculosis].
    Probl Tuberk; 1989 Sep 04; (8):66-71. PubMed ID: 2813318
    [No Abstract] [Full Text] [Related]

  • 14. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
    Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, Gie RP, Cotton MF, van Helden PD, Warren RM, Beyers N.
    Clin Infect Dis; 2006 Feb 15; 42(4):548-58. PubMed ID: 16421800
    [Abstract] [Full Text] [Related]

  • 15. Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children.
    Hesseling AC, Schaaf HS, Hanekom WA, Beyers N, Cotton MF, Gie RP, Marais BJ, van Helden P, Warren RM.
    Clin Infect Dis; 2003 Nov 01; 37(9):1226-33. PubMed ID: 14557968
    [Abstract] [Full Text] [Related]

  • 16. Adverse effects of bacille Calmette-Guerin vaccination in HIV-positive infants.
    Hussey G, Hawkridge T, Eley B, Nuttall J, Kibel M, Geiter L, Barker L, Behr M, Demers AM.
    Clin Infect Dis; 2004 May 01; 38(9):1333-4; author reply 1334-5. PubMed ID: 15127353
    [No Abstract] [Full Text] [Related]

  • 17. [Reasons for postponing anti-tuberculosis BCG vaccination of newborn infants].
    Demeshko ND.
    Probl Tuberk; 1990 May 01; (3):8-10. PubMed ID: 2367513
    [Abstract] [Full Text] [Related]

  • 18. [BCG vaccination].
    Stögmann W.
    Wien Med Wochenschr; 1991 May 01; 141(12):265-70. PubMed ID: 1949819
    [Abstract] [Full Text] [Related]

  • 19. BCG vaccination in children born to HIV-positive mothers.
    Matondo P.
    Lancet; 1992 Sep 26; 340(8822):800. PubMed ID: 1356222
    [No Abstract] [Full Text] [Related]

  • 20. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
    Araujo Z, de Waard JH, de Larrea CF, Borges R, Convit J.
    Vaccine; 2008 Oct 16; 26(44):5575-81. PubMed ID: 18723065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.